Chikashi Asami

Chikashi Asami

Auto-generated profile, based on publicly available information

Chikashi Asami

Cosmic Corporation Co., Ltd., Tokyo, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
MHMin Hu
Min Hu
CAChikashi Asami
Chikashi Asami
HIHiroshi Iwakura
Hiroshi Iwakura
YNYasuyo Nakajima
Yasuyo Nakajima
RSRyousuke Sema
Ryousuke Sema
YSYasubumi Sakakibara
Yasubumi Sakakibara
Approximately 2.4 million patients in Japan need treatment for thyroid disease, including Graves’ disease and Hashimoto’s disease. However, only 450,000 of them are receiving treatment, and many patients with thyroid dysfunction remain largely overlooked. In this retrospective study, we aimed to screen patients with hyperthyroidism and hypothyroidism who would greatly benefit from prompt medical treatment. We examined routine laboratory finding data and machine learning algorithms to investigate whether such accurate and robust screening is possible to prevent overlooking and misdiagnosing thyroid dysfunction. We succeeded in developing a machine learning method to construct a classification model for detecting hyperthyroidism and hypothyroidism in patients using 11 routine laboratory tests. We collected electronic health records and medical checkup data from four hospitals in Japan. As a result of cross-validation and external evaluation, we achieved a high classification accuracy for the hyperthyroidism and hypothyroidism models.